The startup operates a plasma collection service that facilitates the donation of plasma from volunteers for use in life-saving therapies. This process provides essential treatment for patients suffering from rare chronic diseases, such as hereditary angioedema, by ensuring a steady supply of high-quality plasma.
Funding
$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with rare chronic diseases, such as hereditary angioedema, require plasma-derived therapies to manage their conditions. A consistent supply of high-quality plasma is crucial for manufacturing these life-saving treatments, but sourcing enough plasma through traditional methods can be challenging.
Solution
thplasma operates plasma donation centers where healthy individuals can donate plasma to be used in the production of life-saving therapies. The company facilitates a safe and efficient donation process, ensuring that donors are compensated for their time and contribution. By providing a convenient and welcoming environment, thplasma encourages regular donations, helping to maintain a stable supply of plasma for patients in need. The company utilizes advanced plasma collection systems to optimize the donation process and improve the donor experience.
Target Audience
The primary target audience is healthy adults aged 18-65 who meet specific weight and health requirements and are willing to donate plasma regularly.
Features
- Multiple donation center locations with convenient access
- Walk-in appointments welcome
- Prepaid Visa cards for immediate donor compensation
- PaySign app and kiosk for balance tracking and ATM access
- NexSys PCS plasma collection system for increased efficiency
- Thorough medical screening and donor questionnaire
- Stringent safety protocols to ensure donor well-being